LncRNA PCED1B-AS1 Inhibits Sepsis-Induced Acute Kidney Injury by Promoting Transformation of Macrophages from M1 to

Peng Huang1,2, Youfu Li3, SiDan Wang1

  • 1Department of Nephrology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise City, Guangxi, People's Republic of China.

PubMed
Abstract

Insights

Long non-coding RNA PCED1B-AS1 is downregulated in sepsis-induced acute kidney injury (AKI). Upregulating PCED1B-AS1 may inhibit AKI by promoting M2 macrophage polarization via the miR-361-3p/SOCS1 axis.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Sepsis-induced acute kidney injury (AKI) is a critical complication in intensive care with poor outcomes.
  • Understanding the molecular mechanisms underlying sepsis-AKI is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the expression of PCED1B-AS1 in sepsis-induced AKI.
  • To explore the potential molecular mechanism of PCED1B-AS1 in sepsis-AKI.

Main Methods:

  • RT-qPCR to quantify PCED1B-AS1 levels in patients and cell models.
  • In vitro models using RAW264.7 and HK-2 cells to study macrophage polarization and renal injury.
  • CCK-8, flow cytometry, and ELISA to assess cell viability, apoptosis, and inflammatory factors.
  • Dual-luciferase assay to validate the PCED1B-AS1/miR-361-3p/SOCS1 axis interaction.

Main Results:

  • PCED1B-AS1 expression was significantly downregulated in sepsis patients, with further reduction in AKI patients.
  • PCED1B-AS1 levels could distinguish healthy individuals, non-AKI sepsis patients, and AKI patients, correlating with prognosis.
  • Overexpression of PCED1B-AS1 promoted M1 to M2 macrophage polarization, inhibited HK-2 cell apoptosis, and reduced inflammation via the miR-361-3p/SOCS1 pathway.

Conclusions:

  • PCED1B-AS1 may serve as a valuable diagnostic and prognostic biomarker for sepsis-induced AKI.
  • PCED1B-AS1 inhibits sepsis-induced AKI by modulating macrophage polarization and inflammatory responses through the miR-361-3p/SOCS1 axis.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
870
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
562
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
256
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
804